The compound has long been investigated in the patent literature for its anxiolytic Homes and diminished sedative, hypnotic, and ataxic facet-outcomes, but it does not look like certified for health-related use. Łukasik-Głebocka et al Flubromazolam was 1st identified within a sample of 10 white rectangle shaped tablets labelled “XANAX”, seized https://pasteldirectory.com/listings12840528/a-secret-weapon-for-flubromazolam-for-sale-in-europe